KL and diabetic kidney disease: Experimental studies have demonstrated that SGLT2 inhibitors prevent the downregulation of Klotho by inflammatory cytokines and high glucose in renal tubular cells, while they improved serum and urine Klotho levels and decreased urinary inflammatory markers and albuminuria in patients with early diabetic nephropathy [58].